Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Disrupt PAD III: Lithoplasty vs Angioplasty for Calcified PAD
NCT02923193Completed
- Sponsor
- Shockwave Medical
- Start
- Feb 2017
- Primary completion
- May 2020
- Countries
- 4
01
Overview
Randomised, single-blind trial in Peripheral Arterial Disease (PAD) (2 arms), sponsored by Shockwave Medical. Primary endpoint: Procedural Success. Started Feb 2017; status: completed.
02
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT02923193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02923193.